Matthew P. Young

2019

In 2019, Matthew P. Young earned a total compensation of $3.6M as Former Executive Vice President and CFO at Jazz Pharmaceuticals, a 7% increase compared to previous year.

Compensation breakdown

Option Awards$1,291,182
Salary$601,253
Stock Awards$1,680,359
Other$10,585
Total$3,583,378

Young received $1.7M in stock awards, accounting for 47% of the total pay in 2019.

Young also received $1.3M in option awards, $601.3K in salary and $10.6K in other compensation.

Rankings

In 2019, Matthew P. Young's compensation ranked 3,385th out of 13,971 executives tracked by ExecPay. In other words, Young earned more than 75.8% of executives.

ClassificationRankingPercentile
All
3,385
out of 13,971
76th
Division
Manufacturing
1,227
out of 5,701
79th
Major group
Chemicals And Allied Products
417
out of 2,200
81st
Industry group
Drugs
345
out of 1,886
82nd
Industry
Pharmaceutical Preparations
258
out of 1,398
82nd

Pay ratio

Matthew P. Young's Pay$3,583,378
Median Employee's Pay$214,881
Pay Ratio

17

to 1

In 2019, the annual total compensation of Matthew P. Young was $3,583,378.

The annual total compensation of the median employee at Jazz Pharmaceuticals was $214,881.

The ratio of Matthew P. Young's pay to the pay of median employee was therefore 17 to one.

Source: SEC filing on June 12, 2020.

Young's colleagues

We found six more compensation records of executives who worked with Matthew P. Young at Jazz Pharmaceuticals in 2019.

2019

Bruce Cozadd

Jazz Pharmaceuticals

Chief Executive Officer

2019

Daniel Swisher

Jazz Pharmaceuticals

Chief Operating Officer

2019

Robert Iannone

Jazz Pharmaceuticals

Executive Vice President, Research and Development

2019

Robert Ianonne

Jazz Pharmaceuticals

Chief Medical Officer

2019

Robert MSCE

Jazz Pharmaceuticals

Executive Vice President, Global Head of Research and Development

2019

Neena Patil

Jazz Pharmaceuticals

Senior Vice President and GC

News

You may also like